Medullary Thyroid Cancer (MTC)

Also known as: Thyroid Carcinoma, Medullary / Medullary carcinoma of thyroid / Thyroid Gland Medullary Carcinoma / Thyroid Medullary Carcinoma / Thyroid Cancer, Medullary / Medullary Thyroid Carcinoma / Medullary Thyroid Cancer / Parafollicular cell carcinoma (disorder) / Medullary carcinoma with amyloid stroma (morphologic abnormality) / Medullary thyroid carcinoma (disorder)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB08875	Cabozantinib	Not Available	Approved for Marketing	1
DB05153	Cabozantinib	Not Available	Completed	1
DB08875	Cabozantinib	Not Available	Completed	1
DB14554	Dotatate	Not Available	No Longer Available	1
DB13134	Fluorine F-18	Not Available	Recruiting	1
DB00317	Gefitinib	Not Available	Completed	1
DB09078	Lenvatinib	Not Available	Completed	1
DB15822	Pralsetinib	Not Available	Approved for Marketing	1
DB15685	Selpercatinib	Not Available	Available	1
DB17503	PP-F11N lutetium Lu-177	0	Completed	1
DB09292	Sacubitril	0	Completed	1
DB00177	Valsartan	0	Completed	1
DB08875	Cabozantinib	1	Completed	1
DB00958	Carboplatin	1	Completed	1
DB08862	Cholecystokinin	1	Recruiting	1
DB05759	Cixutumumab	1	Completed	1
DB12250	Cixutumumab	1	Completed	1
DB13925	Dotatate gallium Ga-68	1	Recruiting	1
DB15631	Edodekin alfa	1	Completed	1
DB01590	Everolimus	1	Completed	2
DB14123	Menthol	1	Completed	1
DB19196	Minigastrin	1	Recruiting	1
DB15721	Natural Killer Cell	1	Completed	1
DB00104	Octreotide	1	Completed	1
DB00338	Omeprazole	1	Completed	1
DB17503	PP-F11N lutetium Lu-177	1	Recruiting	1
DB01229	Paclitaxel	1	Completed	1
DB00863	Ranitidine	1	Completed	1
DB00020	Sargramostim	1	Completed	1
DB00877	Sirolimus	1	Completed	1
DB16568	Succinylated gelatin	1	Completed	1
DB06287	Temsirolimus	1	Completed	1
DB00072	Trastuzumab	1	Completed	1
DB05294	Vandetanib	1	Completed	1
DB04879	Vatalanib	1	Completed	1
DB00361	Vinorelbine	1	Completed	1
DB00188	Bortezomib	1 / 2	Terminated	1
DB16741	Bortezomib D-mannitol	1 / 2	Terminated	1
DB01234	Dexamethasone	1 / 2	Terminated	1
DB00145	Glycine	1 / 2	Completed	1
DB05381	Histamine	1 / 2	Completed	1
DB19068	IMT-288	1 / 2	Completed	1
DB00836	Loperamide	1 / 2	Unknown Status	1
DB15822	Pralsetinib	1 / 2	Completed	1
DB13017	Rovalpituzumab tesirine	1 / 2	Terminated	1
DB15685	Selpercatinib	1 / 2	Recruiting	2
DB05294	Vandetanib	1 / 2	Completed	1
DB05294	Vandetanib	1 / 2	Terminated	1
DB08875	Cabozantinib	2	Active Not Recruiting	1
DB08875	Cabozantinib	2	Terminated	1
DB14554	Dotatate	2	Not Yet Recruiting	1
DB01590	Everolimus	2	Completed	1
DB17532	GI-6207	2	Completed	1
DB09078	Lenvatinib	2	Terminated	1
DB14509	Lithium carbonate	2	Terminated	1
DB13985	Lutetium Lu 177 dotatate	2	Not Yet Recruiting	1
DB09079	Nintedanib	2	Completed	1
DB06663	Pasireotide	2	Completed	1
DB09037	Pembrolizumab	2	Completed	1
DB08901	Ponatinib	2	Withdrawn	1
DB15685	Selpercatinib	2	Active Not Recruiting	1
DB15685	Selpercatinib	2	Recruiting	1
DB00398	Sorafenib	2	Terminated	1
DB00398	Sorafenib	2	Withdrawn	1
DB01268	Sunitinib	2	Completed	1
DB06398	Tanespimycin	2	Completed	1
DB05294	Vandetanib	2	Terminated	1
DB02546	Vorinostat	2	Completed	1
DB11885	Anlotinib	2 / 3	Completed	1
DB08875	Cabozantinib	3	Active Not Recruiting	1
DB08875	Cabozantinib	3	Withdrawn	1
DB15822	Pralsetinib	3	Withdrawn	1
DB15685	Selpercatinib	3	Active Not Recruiting	1
DB05294	Vandetanib	3	Active Not Recruiting	2
DB05294	Vandetanib	3	Withdrawn	1
DB11885	Anlotinib	4	Recruiting	1
DB05153	Cabozantinib	4	Active Not Recruiting	1
DB08875	Cabozantinib	4	Active Not Recruiting	1